Ryoko Araki

Ryoko Araki

Auto-generated profile, based on publicly available information

Ryoko Araki

Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
SWSayaka Wakayama
Sayaka Wakayama
DIDaiyu Ito
Daiyu Ito
YKYuko Kamada
Yuko Kamada
TSToru Shimazu
Toru Shimazu
TSTomomi Suzuki
Tomomi Suzuki
TWTeruhiko Wakayama
Teruhiko Wakayama
The effect of space radiation on offspring was evaluated using mouse freeze-dried spermatozoa preserved on the Space Station.

10 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
RARyoko Araki
Ryoko Araki
YHYuko Hoki
Yuko Hoki
TSTomo Suga
Tomo Suga
COChizuka Obara
Chizuka Obara
MSMisato Sunayama
Misato Sunayama
MAMasumi Abe
Masumi Abe
A number of point mutations have been identified in reprogrammed pluripotent stem cells such as iPSCs and ntESCs. The molecular basis for these mutations has remained elusive however, which is a considerable impediment to their potential medical application. Here we report a specific stage at which iPSC generation is not reduced in response to ionizing radiation, i.e. radio-resistance. Quite intriguingly, a G1/S cell cycle checkpoint deficiency occurs in a transient fashion at the initial stage of the genome reprogramming process. These cancer-like phenomena, i.e. a cell cycle checkpoint deficiency resulting in the accumulation of point mutations, suggest a common developmental pathway between iPSC generation and tumorigenesis. This notion is supported by the identification of specific cancer mutational signatures in these cells. We describe efficient generation of human integration-free iPSCs using erythroblast cells, which have only a small number of point mutations and INDELs, none of which are in coding regions.

1 December 2001 in Gene
Verified
Journal Article
Closed access
TOTatsuya Ohhata
Tatsuya Ohhata
RARyoko Araki
Ryoko Araki
RFRyutaro Fukumura
Ryutaro Fukumura
KAKuroiwa Asato
Kuroiwa Asato
MYMatsuda Yoichi
Matsuda Yoichi
MAMasumi Abe
Masumi Abe

23 September 2021 in Stem Cell Reports
Verified
Journal Article
Open access
SKSatoshi Kamimura
Satoshi Kamimura
TSTomo Suga
Tomo Suga
YHYuko Hoki
Yuko Hoki
MSMisato Sunayama
Misato Sunayama
KIKaori Imadome
Kaori Imadome
MAMasumi Abe
Masumi Abe
We here demonstrate that microsatellite (MS) alterations are elevated in both mouse and human induced pluripotent stem cells (iPSCs), but importantly we have now identified a type of human iPSC in which these alterations are considerably reduced. We aimed in our present analyses to profile the InDels in iPSC/ntESC genomes, especially in MS regions. To detect somatic de novo mutations in particular, we generated 13 independent reprogramed stem cell lines (11 iPSC and 2 ntESC lines) from an identical parent somatic cell fraction of a C57BL/6 mouse. By using this cell set with an identical genetic background, we could comprehensively detect clone-specific alterations and, importantly, experimentally validate them. The effectiveness of employing sister clones for detecting somatic de novo mutations was thereby demonstrated. We then successfully applied this approach to human iPSCs. Our results require further careful genomic analysis but make an important inroad into solving the issue of genome abnormalities in iPSCs.

11 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
RARyoko Araki
Ryoko Araki
TSTomo Suga
Tomo Suga
YHYuko Hoki
Yuko Hoki
KIKaori Imadome
Kaori Imadome
MSMisato Sunayama
Misato Sunayama
MAMasumi Abe
Masumi Abe
Genomic aberrations are a critical impediment for the safe medical use of iPSCs and their origin and developmental mechanisms remain unknown. Here we find through WGS analysis of human and mouse iPSC lines that genomic mutations are de novo events and that, in addition to unmodified cytosine base prone to deamination, the DNA methylation sequence CpG represents a significant mutation-prone site. CGI and TSS regions show increased mutations in iPSCs and elevated mutations are observed in retrotransposons, especially in the AluY subfamily. Furthermore, increased cytosine to thymine mutations are observed in differentially methylated regions. These results indicate that in addition to deamination of cytosine, demethylation of methylated cytosine, which plays a central role in genome reprogramming, may act mutagenically during iPSC generation.

3 April 2023
Verified
Other
Open access
RZRong ZHANG
Rong ZHANG
TLTian-Yi Liu
Tian-Yi Liu
SSSatoru Senju
Satoru Senju
MHMiwa Haruta
Miwa Haruta
NHNarumi Hirosawa
Narumi Hirosawa
YUYasushi Uemura
Yasushi Uemura